Regenxbio (RGNX) Operating Margin Growth (5y) (2019 - 2026)
Regenxbio (RGNX) Operating Margin Growth (5y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Regenxbio | 583.35 Mn | 477.83 Mn | 106.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 26,410.00 |
| Dec 31, 2025 | 3,788.00 |
| Sep 30, 2025 | -19,038.00 |
| Jun 30, 2025 | -4,374.00 |
| Mar 31, 2025 | 22,760.00 |
| Dec 31, 2024 | 10,052.00 |
| Sep 30, 2024 | -1,236.00 |
| Jun 30, 2024 | 21,135.00 |
| Mar 31, 2024 | 364,556.00 |
| Dec 31, 2023 | -29,369.00 |
| Sep 30, 2023 | 20,362.00 |
| Jun 30, 2023 | -38,182.00 |
| Mar 31, 2023 | -42,275.00 |
| Dec 31, 2022 | 62,932.00 |
| Sep 30, 2022 | 132,701.00 |
| Jun 30, 2022 | 3,791.00 |
| Mar 31, 2022 | 471,587.00 |
| Dec 31, 2021 | 128,556.00 |
| Sep 30, 2021 | 1.47 Mn |
| Jun 30, 2021 | 39,254.00 |